Antisense Therapeutics Ltd (ANP.AX) Quote| Reuters.com
Edition:
United States

Antisense Therapeutics Ltd (ANP.AX)

ANP.AX on Australia Stock Exchange

0.03AUD
1 Jul 2016
Change (% chg)

$0.00 (+9.68%)
Prev Close
$0.03
Open
$0.03
Day's High
$0.04
Day's Low
$0.03
Volume
63,580
Avg. Vol
212,299
52-wk High
$0.12
52-wk Low
$0.03

ANP.AX

Chart for ANP.AX

About

Antisense Therapeutics Limited (Antisense Therapeutics) is an Australia-based antisense technology company. The Company is engaged in the research and development of antisense pharmaceuticals. The Company's segments include ATL 1102 - Multiple Sclerosis and ATL 1103 - Growth and Sight Disorders. The Company's product pipeline... (more)
No analyst recommendations are available for ANP.AX.

Overall

Beta: -0.05
Market Cap(Mil.): $5.47
Shares Outstanding(Mil.): 176.51
Dividend: --
Yield (%): --

Financials

  ANP.AX Industry Sector
P/E (TTM): 7.79 41.10 35.71
EPS (TTM): 0.00 -- --
ROI: 14.37 -6.56 14.23
ROE: 14.37 -5.98 15.43

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : GlobalData
$300.00
Provider : Wright Reports
$75.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.